Avalo Therapeutics, Inc. (AVTX) revenue

Revenue · fiscal 2025
$59.00K

Avalo Therapeutics, Inc. (AVTX) reported revenue of $59.00K in fiscal 2025 (the year ended December 31, 2025). That is 86.6% lower than the $441.00K of fiscal 2024. Figures as of 18 Nov 2026, 09:26 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$59.00K
Change on fiscal 2024
−86.6%
Growth, 5 years
−61.2% a year
Highest on record
$27.81Mfiscal 2017
Lowest on record
$59.00Kfiscal 2025
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Avalo Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 61.2% a year. Across the 10 fiscal years on record (2016–2025), the highest was $27.81M in fiscal 2017 and the lowest $59.00K in fiscal 2025.

History · 10 fiscal years

Revenue by fiscal year

Avalo Therapeutics, Inc. revenue, year by year

Avalo Therapeutics, Inc. (AVTX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$59.00K 86.6% down
2024$441.00K 77.1% down
2023$1.92M 89.3% down
2022$18.05M 234.4% up
2021$5.40M 19.4% down
2020$6.70M 0.8% down
2019$6.75M 4.0% down
2018$7.03M 74.7% down
2017$27.81M 2,312.3% up
2016$1.15M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on AVTX

Avalo Therapeutics, Inc., figure by figure

Avalo Therapeutics, Inc. (AVTX) overview: price, valuation and scorecard

Avalo Therapeutics, Inc. revenue: questions and answers

What is Avalo Therapeutics, Inc.'s revenue?

Avalo Therapeutics, Inc. (AVTX) reported revenue of $59.00K in fiscal 2025 (the year ended December 31, 2025). That is 86.6% lower than the $441.00K of fiscal 2024.

What is the growth rate of Avalo Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 61.2% a year.

What are the highest and lowest revenue figures on record for Avalo Therapeutics, Inc.?

Across the 10 fiscal years on record (2016–2025), the highest was $27.81M in fiscal 2017 and the lowest $59.00K in fiscal 2025.

How is Avalo Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Avalo Therapeutics, Inc. it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Avalo Therapeutics, Inc. (AVTX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/AVTX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.